Market Value115,611,000
Total Holdings64
File Date2018-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
PGEN / Precigen, Inc.
MRK / Merck & Co., Inc.
CLVS / Clovis Oncology Inc
PCRX / Pacira BioSciences, Inc.
SNR / New Senior Investment Group Inc
PGNX / Progenics Pharmaceuticals, Inc.
BIVV / Bioverativ Inc.
TSRO / TESARO, Inc.
SAGE / Sage Therapeutics, Inc. Put
LOXO / Loxo Oncology, Inc.
CFRX / ContraFect Corp
PRTK / Paratek Pharmaceuticals Inc.
LLY / Eli Lilly and Company Call
AVXS / AveXis, Inc.
MDCO / Medicines Company
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
US0153511094 / Alexion Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc. Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
451731103 / Ignyta, Inc.
JUNO / Juno Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
AKBA / Akebia Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
PFE / Pfizer Inc.
HRTX / Heron Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
ADMS / Adamas Pharmaceuticals Inc
BMY / Bristol-Myers Squibb Company
BMY / Bristol-Myers Squibb Company Call
ALNY / Alnylam Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation
GILD / Gilead Sciences, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.
IQV / IQVIA Holdings Inc.
BIIB / Biogen Inc.
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
BMRN / BioMarin Pharmaceutical Inc.
AMGN / Amgen Inc.
PRQR / ProQR Therapeutics N.V.
LGND / Ligand Pharmaceuticals Incorporated
SGEN / Seagen Inc
INCY / Incyte Corporation
FGEN / FibroGen, Inc.
TECH / Bio-Techne Corporation
RARE / Ultragenyx Pharmaceutical Inc.
ICPT / Intercept Pharmaceuticals Inc
IBB / iShares Trust - iShares Biotechnology ETF
NKTR / Nektar Therapeutics
CKPT / Checkpoint Therapeutics, Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
CELG / Celgene Corp.
NBIX / Neurocrine Biosciences, Inc.
CRL / Charles River Laboratories International, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
ALKS / Alkermes plc
ILMN / Illumina, Inc.
REPH / Societal CDMO Inc
REGN / Regeneron Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc. Call
MTD / Mettler-Toledo International Inc.
QGEN / Qiagen N.V.
IONS / Ionis Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.